跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SITAGLIPTIN/METFORMIN SANDOZ XR 50/1000 sitagliptin (as hydrochloride monohydrate)/metformin hydrochloride 50 mg/1000 mg extended release tablet bottle - TGA Drug Approval Details
Approvals
/
TGA
/
SITAGLIPTIN/METFORMIN SANDOZ XR 50/1000 sitagliptin (as hydrochloride monohydrate)/metformin hydrochloride 50 mg/1000 mg extended release tablet bottle
Approved
STANDARD
SITAGLIPTIN/METFORMIN SANDOZ XR 50/1000 sitagliptin (as hydrochloride monohydrate)/metformin hydrochloride 50 mg/1000 mg extended release tablet bottle
Sandoz Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
4bdeae5da09a2e5f
Company
Sandoz Pty Ltd
Type
Standard
Approval Details
Approval Id
4bdeae5da09a2e5f
Product Name
SITAGLIPTIN/METFORMIN SANDOZ XR 50/1000 sitagliptin (as hydrochloride monohydrate)/metformin hydrochloride 50 mg/1000 mg extended release tablet bottle
Artg Id
369591
Artg Name
SITAGLIPTIN/METFORMIN SANDOZ XR 50/1000 sitagliptin (as hydrochloride monohydrate)/metformin HCl 50mg/1000mg extended release tablet bottle
Sponsor
Sandoz Pty Ltd
Company Detail Path
/organization/sandoz-pty-ltd
Artg Date
2023-05-19
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2023-CMI-02740-1
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2023-PI-01685-1
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
4bdeae5da09a2e5f
Type
Standard
Back to TGA Approvals